Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 1998, p. 453-455, Vol. 42, No. 2
Department of Pharmaceutical Services,
Kumamoto University Hospital, 1-1-1 Honjo, Kumamoto 860, Japan
Received 29 July 1996/Returned for modification 15 June
1997/Accepted 1 November 1997
This study was designed to determine the influence of aluminum
hydroxide and famotidine on the bioavailability of tosufloxacin. Coadministration of aluminum hydroxide reduced the bioavailability of
tosufloxacin by 31.6% (P < 0.05). Famotidine did not
alter tosufloxacin absorption. To avoid potential treatment failures, the concurrent use of tosufloxacin and aluminum hydroxide should be
avoided altogether.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Effects of Aluminum Hydroxide and Famotidine on Bioavailability
of Tosufloxacin in Healthy Volunteers
and
*
Corresponding author. Mailing address: Department of
Pharmaceutical Services, Kumamoto University Hospital, 1-1-1 Honjo,
Kumamoto 860-0811, Japan. Phone: (81)96-373-5820. Fax: (81)96-373-5906. E-mail: nakano{at}kaiju.medic.kumamoto-u.ac.jp.
Present address: Department of Hospital Pharmacy, Tokyo Medical and
Dental University School of Medicine, Tokyo 113, Japan.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»